Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GNPX
#4509
Genprex, Inc. Common Stock
2.010
0
USD
+2.55%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.55%
Monthly Change
+7.49%
6 month change
+7.49%
Year Change
+7.49%
Previous Close
1.960
0
Open
2.010
0
Bid
2.010
0
Ask
2.013
0
Low
2.010
0
High
2.010
0
Volume
16
Markets
US Stock Market
Healthcare
GNPX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
21.64 K
23.94 K
25.99 K
38.21 K
483.06 K
—
Valuation ratios
Enterprise value
—
—
—
—
-1.19 M
-6.44 M
Price to earnings ratio
—
—
—
—
-0
-0.01
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
-0
-0.01
Price to book ratio
—
—
—
—
0.04
0.05
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.57
-0.46
-0.95
-2.89
-5.12
-4
Return on equity %
0.58
-0.47
-1.07
-4.16
-13.03
-12.01
Return on invested capital %
—
—
—
-2 488.32
-1 999.88
—
Gross margin %
—
—
—
—
—
400
Operating margin %
—
—
—
—
—
-228.1 M
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
-227.51 M
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
68.15
24.69
7.64
2.31
0.83
4.29
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-741.53
-904.36
-214.04
-63.46
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
873.96
246.3
19.99
35.24
Net current asset value per share
—
—
895.61
275.33
25.93
45.55
Tangible book value per share
—
—
899.76
242.84
20.22
36.42
Working capital per share
—
—
778.4
156.37
-5.33
-0.49
Book value per share
—
—
929.04
271.12
20.22
36.42
News
Genprex stock jumps on Japan, Europe patent approvals
Genprex receives Japanese and European patents for cancer therapy
Genprex receives patent approval in Australia for cancer therapy
Genprex reports positive data for diabetes gene therapy in animal studies
Genprex reports potential compliance with Nasdaq equity listing rule
Genprex reports phase 1 data for lung cancer gene therapy
Genprex receives US patent for cancer therapy combination
Genprex to receive European patent for cancer gene therapy combination
Genprex stock tumbles after announcing $3.4 million registered offering
Genprex announces $3.4 million registered direct offering
Genprex stock soars after positive preclinical lung cancer treatment data
Genprex reports positive preclinical data for lung cancer gene therapy